Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion type Assertion NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_head.
- NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion description "[The aim of the present study was to analyse the antiproliferative effects and mechanisms of action of protein kinase inhibitors (PKIs) in human glioblastoma multiforme (GBM) cells with different epidermal growth factor receptor (EGFR) and phosphatase and tensin homologue (PTEN) status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_provenance.
- NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion evidence source_evidence_literature NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_provenance.
- NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion SIO_000772 23110505 NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_provenance.
- NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion wasDerivedFrom befree-20150227 NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_provenance.
- NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_assertion wasGeneratedBy ECO_0000203 NP370540.RAQ1lHyBXKqv2PUtzzV0aeUFr2kgBMQd9vs_RUeC02LUA130_provenance.